Jump Financial’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
Other funds holding KURA
SCM
BI
AC
ACM
Jump Financial's KURA Position: Q2 2026 in Review
Jump Financial increased its Kura Oncology (KURA) stake by 34% in Q2 2026, buying an estimated $1.6M and bringing the position to 675,044 shares worth $7.41M. The position accounts for 0.06% of the portfolio, ranked #357.
Jump Financial first reported a position in KURA in Q4 2020 and has held it in 15 quarters since. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.
- Jump Financial held 675,044 shares of Kura Oncology worth $7.41M as of Q2 2026.
- Jump Financial bought 169,592 Kura Oncology shares in Q2 2026, an estimated $1.6M.
- Kura Oncology made up 0.06% of Jump Financial's portfolio in Q2 2026, its #357 holding.
- Jump Financial first reported a position in Kura Oncology in Q4 2020 and has held it in 15 quarters since.
- 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.
Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.